Tonia C Poteat1, Sari L Reisner2,3, Marissa Miller4, Andrea L Wirtz5. 1. Department of Social Medicine,University of North Carolina Chapel Hill, Chapel Hill, NC. 2. Department of Medicine,Harvard Medical School,Boston, MA. 3. Department of Epidemiology,Harvard T.H. Chan School of Public Health, Boston, MA. 4. TransSolutions LLC, Washington, DC. 5. Department of Epidemiology,Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Abstract
BACKGROUND: COVID-19 is a new pandemic, and its impact by HIV status is unknown. National reporting does not include gender identity; therefore, data are absent on the impact of COVID-19 on transgender people, including those with HIV. Baseline data from the American Cohort to Study HIV Acquisition Among Transgender Women in High Risk Areas (LITE) Study provide an opportunity to examine pre-COVID factors that may increase vulnerability to COVID-19-related harms among transgender women. SETTING: Atlanta, Baltimore, Boston, Miami, New York City, Washington, DC. METHODS: Baseline data from LITE were analyzed for demographic, psychosocial, and material factors that may affect vulnerability to COVID-related harms. RESULTS: The 1020 participants had high rates of poverty, unemployment, food insecurity, homelessness, and sex work. Transgender women with HIV (n = 273) were older, more likely to be Black, had lower educational attainment, and were more likely to experience material hardship. Mental and behavioral health symptoms were common and did not differ by HIV status. Barriers to health care included being mistreated, provider discomfort serving transgender women, and past negative experiences; as well as material hardships, such as cost and transportation. However, most reported access to material and social support-demonstrating resilience. CONCLUSIONS: Transgender women with HIV may be particularly vulnerable to pandemic harms. Mitigating this harm would benefit everyone, given the highly infectious nature of this coronavirus. Collecting gender identity in COVID-19 data is crucial to inform an effective public health response. Transgender-led organizations' response to this crisis serve as an important model for effective community-led interventions.
BACKGROUND: COVID-19 is a new pandemic, and its impact by HIV status is unknown. National reporting does not include gender identity; therefore, data are absent on the impact of COVID-19 on transgender people, including those with HIV. Baseline data from the American Cohort to Study HIV Acquisition Among Transgender Women in High Risk Areas (LITE) Study provide an opportunity to examine pre-COVID factors that may increase vulnerability to COVID-19-related harms among transgender women. SETTING: Atlanta, Baltimore, Boston, Miami, New York City, Washington, DC. METHODS: Baseline data from LITE were analyzed for demographic, psychosocial, and material factors that may affect vulnerability to COVID-related harms. RESULTS: The 1020 participants had high rates of poverty, unemployment, food insecurity, homelessness, and sex work. Transgender women with HIV (n = 273) were older, more likely to be Black, had lower educational attainment, and were more likely to experience material hardship. Mental and behavioral health symptoms were common and did not differ by HIV status. Barriers to health care included being mistreated, provider discomfort serving transgender women, and past negative experiences; as well as material hardships, such as cost and transportation. However, most reported access to material and social support-demonstrating resilience. CONCLUSIONS: Transgender women with HIV may be particularly vulnerable to pandemic harms. Mitigating this harm would benefit everyone, given the highly infectious nature of this coronavirus. Collecting gender identity in COVID-19 data is crucial to inform an effective public health response. Transgender-led organizations' response to this crisis serve as an important model for effective community-led interventions.
Authors: Sari L Reisner; Tonia Poteat; JoAnne Keatley; Mauro Cabral; Tampose Mothopeng; Emilia Dunham; Claire E Holland; Ryan Max; Stefan D Baral Journal: Lancet Date: 2016-06-17 Impact factor: 79.321
Authors: Diego A Martinez; Jeremiah S Hinson; Eili Y Klein; Nathan A Irvin; Mustapha Saheed; Kathleen R Page; Scott R Levin Journal: JAMA Date: 2020-07-28 Impact factor: 56.272
Authors: Jeffrey S Becasen; Christa L Denard; Mary M Mullins; Darrel H Higa; Theresa Ann Sipe Journal: Am J Public Health Date: 2018-11-29 Impact factor: 9.308
Authors: Megan M Marron; Diane G Ives; Robert M Boudreau; Tamara B Harris; Anne B Newman Journal: J Am Geriatr Soc Date: 2018-09-12 Impact factor: 5.562
Authors: Jane Liebschutz; Richard Saitz; Victoria Brower; Terence M Keane; Christine Lloyd-Travaglini; Tali Averbuch; Jeffrey H Samet Journal: J Gen Intern Med Date: 2007-03-10 Impact factor: 5.128
Authors: Santiago Garcia; Mazen S Albaghdadi; Perwaiz M Meraj; Christian Schmidt; Ross Garberich; Farouc A Jaffer; Simon Dixon; Jeffrey J Rade; Mark Tannenbaum; Jenny Chambers; Paul P Huang; Timothy D Henry Journal: J Am Coll Cardiol Date: 2020-04-10 Impact factor: 24.094
Authors: Andrea L Wirtz; Tonia Poteat; Asa Radix; Keri N Althoff; Christopher M Cannon; Andrew J Wawrzyniak; Erin Cooney; Kenneth H Mayer; Chris Beyrer; Allan E Rodriguez; Sari L Reisner Journal: JMIR Res Protoc Date: 2019-10-03
Authors: Tara McKay; Jeff Henne; Gilbert Gonzales; Kyle A Gavulic; Rebecca Quarles; Sergio Garcia Gallegos Journal: Sex Res Social Policy Date: 2021-08-20
Authors: Arjee Javellana Restar; Henri M Garrison-Desany; Tyler Adamson; Chase Childress; Gregorio Millett; Brooke A Jarrett; Sean Howell; Jennifer L Glick; S Wilson Beckham; Stefan Baral Journal: BMC Public Health Date: 2021-05-12 Impact factor: 3.295
Authors: Kelly M Correia; Shannon R Bierma; Sophia D Houston; Madison T Nelson; Khushwant S Pannu; Chase M Tirman; Randi L Cannon; Lauren R Clance; Dawn N Canterbury; Angela N Google; Blair H Morrison; Jeremiah A Henning Journal: J Microbiol Biol Educ Date: 2022-04-05
Authors: Brooke A Jarrett; Sarah M Peitzmeier; Arjee Restar; Tyler Adamson; Sean Howell; Stefan Baral; S Wilson Beckham Journal: medRxiv Date: 2020-11-04
Authors: Daniel Teixeira da Silva; Katie Biello; Willey Y Lin; Pablo K Valente; Kenneth H Mayer; Lisa Hightow-Weidman; José A Bauermeister Journal: Vaccines (Basel) Date: 2021-03-01